Keyword: Eli Lilly

News

Boehringer to Sell Pet Vaccines to Lilly

07.10.2016 - German drugmaker Boehringer Ingelheim is selling the pet vaccines portfolio of its US subsidiary Vetmedica to Eli Lilly’s animal health subsidiary Elanco for $885 million to allay...

News

Sanofi Files Patent Suit Against US Merck

20.09.2016 - French drugmaker Sanofi has filed a patent infringement suit in the United States District Court for the District of Delaware charging US pharmaceutical producer Merck with...

News

Lilly CEO Lechleiter to Retire in December

01.08.2016 - Long-time Eli Lilly chairman and CEO, John C. Lechleiter, has announced plans to retire in December of this year after 30 years with the US drugmaker. Succeeding the 62-year-old...

News

Bayer May Consider Selling Animal Health

14.04.2016 - Bayer is still committed to expanding its animal health business, but would consider selling it if suitable takeover targets remain elusive, newly named CEO Werner Baumann has told...

News

Lilly, AstraZeneca Alzheimer's Trial Advances

11.04.2016 - Eli Lilly and AstraZeneca are moving into Phase 3 of their Amaranth study of AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor that could be a potential treatment...

News

Lilly-backed Study Confirms Evacetrapib Fail

05.04.2016 - Results from the just-concluded studies of the Eli Lilly drug candidate evacetrapib by the Cleveland Clinic in Ohio, USA, have underscored other findings that industry watchers...

Markets & Companies

After Pharma’s Patent Cliff

04.04.2016 - Analysts love looking into the future, particularly when it comes to big pharma’s prospect for growth and earnings. The industry experts of Morningstar see slowing patent losses...

News

Pharma Majors Join Parkinson’s Initiative

24.02.2016 - Major drugs firms AstraZeneca, Pfizer and Eli Lilly are among seven of the world’s largest pharmaceutical companies that have joined a new consortium to improve clinical trials for...